pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisMethodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaMolecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidaseCharacterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidaseSystematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, ChinaEsters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolatesEffect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosisRole of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border regionMolecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity
P2860
Q27004697-2CFB9DA3-3A63-4FE2-B242-3A307F1D3CCBQ27011264-0DB4EDF3-0FBB-4478-A89B-8E7615308D03Q28389409-C9C97891-F44E-436A-9649-0052079F0781Q28480662-637F92A1-6E49-4542-A92E-45BE1E73AA85Q28486585-B40CD874-D86E-4DA4-A627-D4B85EDDA53EQ30419570-A1CC60CE-FD99-496B-BAB3-D78E676855E2Q33752491-04C91FF6-703F-4EBE-A442-44547AF7D97BQ34061907-8453F485-5FFD-411A-8C8E-488AF8917D23Q35076847-9B0A0942-7D9E-44ED-ABD8-A8CDDEDE30FBQ36290784-F2374241-B13D-4542-A7DB-932773D03736Q36297624-B4D4B7B9-ABB8-49CA-883E-7E361F6841C4Q36933512-C60DA48E-E15B-48E0-A242-08FDCE7C31FCQ37215691-CC94248F-937B-4BAC-B3F4-2096B12FA622Q37546627-A45A1CC5-6458-4188-9C51-DE0DAE48024AQ37902409-FC86343A-41E0-4823-9678-D92F5E0780ECQ38718396-8EF0F988-547C-48A9-AF94-4FCC915B13A7Q40328764-C76E1AE1-D4D8-45EA-85BA-4F25467854EBQ40734443-F157AFE8-9020-4972-B666-3C01ABC1A182Q42090699-531EE7DC-46A1-451C-855C-831FCA6B128DQ42618592-8A2387EA-F23C-4AE1-91C8-68CE75012C08Q43237436-730F0118-C0FC-4196-8540-881DABC67592Q43923911-88B840FD-3D06-4DEE-84F3-5F1627C672C9Q47162316-59782514-0A90-4984-8791-9561DB380059Q52586133-362E14B4-2DDB-452F-B851-09638CA307B2Q57222227-1B45BEC8-0FC0-40D8-B8CE-34A273DE1A84
P2860
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@ast
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@en
type
label
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@ast
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@en
prefLabel
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@ast
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.
@en
P2860
P50
P1476
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal
@en
P2093
Laura Brum
P2860
P304
P356
10.1128/AAC.48.7.2736-2738.2004
P407
P577
2004-07-01T00:00:00Z